Immunomodulatory Drugs in Acute Myeloid Leukemia Treatment

SIMPLE SUMMARY: Immunomodulatory drugs (IMiDs) are a class of molecules composed of thalidomide and its analogs. There is a growing interest in IMiDs on the treatment of acute myeloid leukemia (AML) patients. As AML has a worse prognosis, especially in elderly patients, novel drugs such as IMiDs, as...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccolomo, Antonio, Schifone, Claudia Pia, Strafella, Vanda, Specchia, Giorgina, Musto, Pellegrino, Albano, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573974/
https://www.ncbi.nlm.nih.gov/pubmed/32899586
http://dx.doi.org/10.3390/cancers12092528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573974/
https://www.ncbi.nlm.nih.gov/pubmed/32899586
http://dx.doi.org/10.3390/cancers12092528

Ejemplares similares